Taking a New Approach to Stem Cell Regulation

Policing clinics isn’t the right move; instead, the FDA needs to consider the concerns of key stakeholders.

Editorial by:

Ana Iltis, PhD, Wake Forest University & Kirstin Matthews, PhD, Rice University

Publication:

See the Houston Chronicle, December 15, 2015:  View Editorial